CLINICAL_TRIALS ClinicalTrials.gov record update

Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02323867
Title field or adapter rule: {'original_value': 'Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-30T23:06:04.999943+00:00
Published At: 2026-10-06T00:00:00+00:00
Record Updated At: 2026-10-06
Results Posted At: 2026-10-06
Source Retrieved At: 2026-10-30T22:07:50.731291+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

protocolSection.conditionsModule.conditions: ["Leukemia", "Lymphoma", "Myelodysplasia"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-06", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT02323867"
protocolSection.identificationModule.officialTitle: "Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct: {"date": "2026-10-06", "type": "ACTUAL"}

{'armGroupLabels': ['CliniMACS αβ T-Cell/CD19+ B-Cell Depleted Peripheral Blood Stem Cell Transplant'], 'description': 'Allogeneic hematopoietic stem cell transplantation using mobilized peripheral blood stem cells from unrelated or partially matched related donors. The stem cell product is processed ex vivo using the CliniMACS device to selectively deplete TCR α/β T cells and CD19+ B cells prior to infusion. The final graft retains CD34+ stem cells, NK cells, and γ/δ T cells.', 'name': 'CliniMACS α/β T-Cell and CD19+ B-Cell Depleted Peripheral Blood Stem Cell Transplant', 'type': 'DEVICE'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.